Accelerating global chemical product innovation and development

Scientific and regulatory support to market and sustain your products in any jurisdiction.

Competitive Advantage

Acta is a global scientific and regulatory consulting firm that assists companies that make and use chemicals with strategic commercialization planning and complex product registration and compliance matters.

We partner with our clients to help them get products quickly and efficiently to market — in any country or locale — and keep them there when challenged by a new regulatory regime, issue, or set of rules.

More About Us

Knowledge & Insights

  March 26, 2024
Memoranda
PFAS – What to Know Now, and What to Expect

Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are attracting global legal, regulatory, commercial, and litigation attention as no other...

  May 21, 2024
Memoranda
Registration Now Open for “TSCA Reform — Eight Years Later” Conference

Registration is now open for “TSCA Reform — Eight Years Later,” the June 26, 2024, day-long conference sponsored by Bergeson & Campbell,...

  May 17, 2024
Memoranda
EPA Holds Webinar on “Reducing PFAS in Products: Progress and Challenges”

On May 8, 2024, the U.S. Environmental Protection Agency’s (EPA) Office of Chemical Safety and Pollution Prevention (OCSPP) held a webinar on...

  April 23, 2024
Memoranda
EPA Designates PFOA and PFOS as CERCLA Hazardous Substances, Releases CERCLA Enforcement Discretion Policy

On April 19, 2024, the U.S. Environmental Protection Agency (EPA) announced a final rule that will designate perfluorooctanoic acid (PFOA),...

  April 22, 2024
Memoranda
EPA Issues Fourth TSCA Test Order for PFAS

The U.S. Environmental Protection Agency (EPA) announced on March 25, 2024, that it has issued the fourth Toxic Substances Control Act (TSCA) test...

  April 12, 2024
Global Regulatory Updates
Global Regulatory Update for April 2024

WEBINAR – Registration Is Open For “Harmonizing TSCA Consent Orders with OSHA HCS 2012”: Register now to join The Acta Group (Acta®) and...

  April 9, 2024
Memoranda
FDA Reports That No Asbestos Was Detected in Its 2023 Testing of Talc-Containing Cosmetic Products

The U.S. Food and Drug Administration (FDA) announced on April 5, 2024, the results of its 2023 sampling assignment, testing talc-containing cosmetic...

Seminars & Webinars

  April 12, 2024
Seminars & Webinars
Sponsor’s Role in Regulatory Testing, June 13, 2024, 11:00 a.m. – 12:00 p.m. (EDT), via webinar

Please note that the date of this webinar has moved forward one day, from Wednesday, June 12, 2024, to Thursday, June 13, 2024. Register now to join...

  May 21, 2024
Seminars & Webinars
There Is More to TSCA Reporting Than CDR: TSCA Sections 8(a), (c), (d), and (e), featuring Dave Turk and Stephanie Griffin from EPA OCSPP, June 18, 2024, 11:00 a.m. – 12:00 p.m. (EDT), via webinar

The U.S. Environmental Protection Agency (EPA) has been using its Toxic Substances Control Act (TSCA) Section 8 authorities in new and different ways....

  March 21, 2024
Seminars & Webinars
TSCA Reform – Eight Years Later, June 26, 2024, George Washington University Milken Institute School of Public Health, Washington, D.C., and via livestream

Register now to attend in-person or virtually the complimentary “TSCA Reform – Eight Years Later” conference, presented by Bergeson &...

With offices in the U.S., UK, and Europe, and partners and agents in China, South Korea, Turkey, Mexico, and more, Acta offers expertise with regulatory programs and chemical product approvals in North America, Europe, South and Central America, and Asia.

Our Firms

our people

Experienced industry and agency scientists, including organic chemists, toxicologists, exposure experts, seven Ph.D.’s. Government affairs and regulatory specialists including nine high-level EPA alumni. Business strategists with decades of experience directing worldwide regulatory compliance.

Acta consultants manage products from concept to approval, delivering skills and experience with specific product areas in government and industry.

Our three affiliated firms -- B&C, Acta, and BCCM -- provide a full range of global support for the commercialization of chemicals, biocides, and products of industrial biotechnology, nanotechnology, and synthetic biology.